omniture
logo
Search
ILDONG PHARMACEUTICAL CO.
Media Room

Latest News

rss

Yunovia Announces IND Approval by the MFDS to Initiate Phase 1 MAD Study for the Small Molecule GLP-1 Agonist

SEOUL, South Korea, Aug. 27, 2024 /PRNewswire/ -- Yunovia, a drug R&D subsidiary of Ildong Pharmace...

2024-08-28 10:43 1525

Ildong Pharmaceutical starts Phase 1 study of new diabetes therapy in Germany

SEOUL, South Korea, July 1, 2021 /PRNewswire/ -- A Phase 1 study on new drug candidate IDG16177 of ...

2021-07-01 21:00 2129